breath analysis

R&D

It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.